The critical findings of the present study are that the treatment of NSCLC cells with honokiol for 24 h inhibits cell migration in a concentration-dependent manner, and that is associated with the inhibition of endogenous expression of COX-2 and production of PGE2. This evidence concerns the gene PTGS2 and non-small cell lung carcinoma.